Cargando…

Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?

Cardiovascular diseases (CVD) are the leading cause of premature death and disability in humans that are closely related to lipid metabolism and signaling. This study aimed to assess whether circulating lysophospholipids (LPL), lysophosphatidic acids (LPA) and monoacylglycerols (MAG) may be consider...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duflot, Thomas, Tu, Ly, Leuillier, Matthieu, Messaoudi, Hind, Groussard, Déborah, Feugray, Guillaume, Azhar, Saïda, Thuillet, Raphaël, Bauer, Fabrice, Humbert, Marc, Richard, Vincent, Guignabert, Christophe, Bellien, Jérémy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621392/ https://www.ncbi.nlm.nih.gov/pubmed/34822442 http://dx.doi.org/10.3390/metabo11110784

Ejemplares similares

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats
por: Leuillier, Matthieu, et al.
Publicado: (2023)

Pulmonary hypertension associated with neurofibromatosis type 2
por: Taniguchi, Hirohisa, et al.
Publicado: (2021)

Determination of Lipoxygenase, CYP450, and Non-Enzymatic Metabolites of Arachidonic Acid in Essential Hypertension and Type 2 Diabetes
por: Feugray, Guillaume, et al.
Publicado: (2022)

Subtotal Nephrectomy Associated with a High-Phosphate Diet in Rats Mimics the Development of Calcified Aortic Valve Disease Associated with Chronic Renal Failure
por: Messaoudi, Hind, et al.
Publicado: (2023)

Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis
por: Cauvet, Anne, et al.
Publicado: (2023)

A genome-wide association analysis identifies PDE1A|DNAJC10 locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese population
por: Kimura, Mai, et al.
Publicado: (2017)

Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis
por: Günther, Sven, et al.
Publicado: (2018)

Platelet‐Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension
por: Solinc, Julien, et al.
Publicado: (2022)

Pathogenesis of pulmonary arterial hypertension: lessons from cancer
por: Guignabert, Christophe, et al.
Publicado: (2013)

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury
por: Leuillier, Matthieu, et al.
Publicado: (2022)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients
por: Duflot, Thomas, et al.
Publicado: (2019)

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
por: Huertas, Alice, et al.
Publicado: (2020)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension
por: da Silva Gonçalves Bos, Denielli, et al.
Publicado: (2017)

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension
por: Ryanto, Gusty R. T., et al.
Publicado: (2021)

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
por: Orvain, Cindy, et al.
Publicado: (2022)

Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis
por: Hlavaty, Alex, et al.
Publicado: (2022)

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
por: Chaumais, Marie-Camille, et al.
Publicado: (2014)

Dendritic Cells in Pulmonary Hypertension: Foot Soldiers or Hidden Enemies?
por: Guignabert, Christophe
Publicado: (2020)

2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)

Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo
por: Yu, Zi-Li, et al.
Publicado: (2018)

Molecular mechanism of lysophosphatidic acid-induced hypertensive response
por: Kano, Kuniyuki, et al.
Publicado: (2019)

Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019)

Lysophosphatidic Acid Signaling in Cancer
por: Brindley, David N.
Publicado: (2020)

T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis
por: Boleto, Gonçalo, et al.
Publicado: (2018)

Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention
por: Sanada, Takayuki Jujo, et al.
Publicado: (2021)

Adaptation of Arterial Wall Viscosity to the Short‐Term Reduction of Heart Rate: Impact of Aging
por: Roca, Frédéric, et al.
Publicado: (2022)

Lysophosphatidic acid in carcinogenesis and tumor development
por: Albrecht, Wiebke
Publicado: (2018)

Regulation of Tumor Immunity by Lysophosphatidic Acid
por: Lee, Sue Chin, et al.
Publicado: (2020)

Lysophosphatidic Acid Signaling in Diabetic Nephropathy
por: Lee, Jong Han, et al.
Publicado: (2019)

Effect of lysophosphatidic acid on the follicular development and the expression of lysophosphatidic acid receptor genes during in vitro culture of mouse ovary
por: Abedpour, Neda, et al.
Publicado: (2018)

Aiming drug discovery at lysophosphatidic acid targets
por: Tigyi, Gabor
Publicado: (2010)

Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
por: Ramesh, Sindhu, et al.
Publicado: (2018)

Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance
por: D’Souza, Kenneth, et al.
Publicado: (2018)

The Role of Lysophosphatidic Acid in Adult Stem Cells
por: Lee, Dongjun, et al.
Publicado: (2020)

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009)

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid–lysophosphatidic acid receptor 1 cascade
por: Miyabe, Yoshishige, et al.
Publicado: (2014)

The autotaxin-lysophosphatidic acid–lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme
por: Tabuchi, Sadaharu
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h42re5b97pr70ltof4qo008af3